Skip Navigation

Staff Detail

Skip sharing on social media links

​​​

Higgins, Rosemary

Formal Title:

 

Responsibilities:

Dr. Rosemary Higgins, a board certified neonatologist, serves as the Program Scientist for the NICHD Neonatal Research Network. In addition, she administers a portfolio of research and training grants concerned with disorders of the newborn, newborn intensive care treatments and technologies and neonatal adaptation and well-being. In 2002, she joined the NIH at NICHD and is responsible for day to day activities in the Neonatal Research Network.

Phone:

301-435-7909

Email:

rh298n@nih.gov

Address:

6100 EXECUTIVE BLVD Room 4B03B, MSC 7510
Bethesda Md 20892-7510
For FedEx use:
Rockville Md 20852

Topics in my portfolio:



Biosketch:

Rosemary D. Higgins, M.D., is a board-certified neonatologist, who joined the Branch in January 2003. She is the program scientist for the NICHD Neonatal Research Network. Prior to joining the Branch, she held faculty positions at New York University Medical Center and at Georgetown University. Dr. Higgins is a member of the Society for Pediatric Research, and is a fellow of the AAP. Dr. Higgins's area of expertise is retinopathy of prematurity.

Publications (PubMed):

Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop.
Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.
Childhood outcomes after hypothermia for neonatal encephalopathy.
Executive summary of the workshop "Nutritional Challenges in the High Risk Infant".
Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.
Causes and timing of death in extremely premature infants from 2000 through 2011.
Neuroimaging and neurodevelopmental outcome in extremely preterm infants.
Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial.
Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).
Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18.
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology